UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement
Sales, net	$ 10,032	$ 10,489	$ 30,408	$ 31,719
Cost of goods sold	4,083	4,012	12,130	12,433
Gross profit	5,949	6,477	18,279	19,286
Operating expense:
Selling, general and administrative	2,159	2,376	6,641	7,226
Research and development	126	140	368	433
Total operating expense	2,285	2,517	7,009	7,660
Operating income	3,665	3,960	11,269	11,627
Other income (expense)	(88)	(111)	(279)	(411)
Income before provision for income taxes	3,577	3,849	10,991	11,215
Provision for income taxes	1,006	1,128	3,052	3,305
Net income	2,571	2,721	7,938	7,910
Earnings per common share (basic)	$ 0.69	$ 0.74	$ 2.13	$ 2.15
Earnings per common share (diluted)	$ 0.68	$ 0.73	$ 2.11	$ 2.13
Shares outstanding (basic)	3,735	3,689	3,724	3,672
Shares outstanding (diluted)	3,781	3,726	3,771	3,706
Other comprehensive income:
Foreign currency translation net of taxes of $0 in all periods	2,573	1,099	76	1,343
Unrealized gain on investments net of taxes of $0, $4, $4 and $6	0	6	6	10
Total comprehensive income	$ 5,145	$ 3,825	$ 8,020	$ 9,263